Results 181 to 190 of about 28,272 (264)

Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. [PDF]

Medicine (Baltimore)
Peng S, Liu M, Du F, Li K.
europepmc   +1 more source

Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study [PDF]

, 2020
Jie Shi, Weiwei Zhang, Yixin Niu, Ning Lin, Xiaoyong Li, Hongmei Zhang, Renming Hu, Guang Ning, Jian‐Gao Fan, Li Qin, Qing Su, Zhen Yang   +11 more
openalex   +1 more source

Dramatic Coronary Artery Aneurysm Regression After Coronary Artery Bypass Grafting and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy. [PDF]

Interdiscip Cardiovasc Thorac Surg
Yokoyama Y, Higashino H, Fujieda H, Abe M.   +3 more
europepmc   +1 more source

The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Active Site and Cleavage Sequence Differentially Regulate Protein Secretion from Proteolysis [PDF]

, 2014
John S. Chorba, Kevan M. Shokat
openalex   +1 more source

Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects. [PDF]

J Transl Med
Bosco G, Di Giacomo Barbagallo F, Di Marco M, Scilletta S, Miano N, Pistritto C, Tiralongo M, Di Stefano C, Pennisi G, De Francesco EM, Malaguarnera R, Di Pino A, Piro S, Scicali R.   +13 more
europepmc   +1 more source

Image_1_Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations and Cardiovascular Events in Cardiovascular Disease: A Systemic Review and Meta-Analysis.TIF

, 2021
Jiahui Liu (724342), Fangfang Fan (312738), Xingyu Luo (3684229), Wenjun Ji (822811), Yaokun Liu (11743949), Yan Zhang (8098), Bo Zheng (170888)   +6 more
openalex   +2 more sources

Targeting proprotein convertase subtilisin/kexin type 9 in mice and monkeys [PDF]

Current Opinion in Lipidology, 2019
Ya, Wang, Murong, Ma, Jian-An, Wang, Alan, Daugherty, Hong S, Lu   +4 more
openaire   +2 more sources

Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia

Chinese Medical Journal, 2022
Yanren Peng, Danxia Guo, Sijie Jiang, Hua Zheng, Lishao Guo   +4 more
doaj   +1 more source

Hemmstudien von rekombinant exprimiertem und gereinigtem Spodoptera frugiperda Furin mittels Peptidinhibitoren - Struktur- und Inhibitionseigenschaften der SFurin-Prodomäne [PDF]

, 2002
Prof. Dr. H. Kindl, Scheffczik, Hanno
core   +1 more source

A novel loop-mediated isothermal amplification-based genotyping method and its application for identifying proprotein convertase subtilisin/kexin type 9 variants in familial hypercholesterolemia

, 2021
Masato Hamasaki, Norimitsu Hosaka, Lita A. Freeman, Masaki Satō, Kazuo Hara, Alan T. Remaley, Kazuhiko Kotani   +6 more
openalex   +1 more source